DOCCHECK AG (AJ91.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:AJ91 - DE000A1A6WE6 - Common Stock
11 EUR
-0.1 (-0.9%)
AJ91 gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 11 industry peers in the Health Care Technology industry. AJ91 gets an excellent profitability rating and is at the same time showing great financial health properties. AJ91 is not valued too expensively and it also shows a decent growth rate. AJ91 also has an excellent dividend rating. This makes AJ91 very considerable for dividend investing!
1. Profitability
1.1 Basic Checks
In the past year AJ91 was profitable.
AJ91 had a positive operating cash flow in the past year.
In the past 5 years AJ91 has always been profitable.
In the past 5 years AJ91 always reported a positive cash flow from operatings.
1.2 Ratios
AJ91 has a Return On Assets of 9.09%. This is amongst the best in the industry. AJ91 outperforms 81.82% of its industry peers.
AJ91 has a better Return On Equity (13.18%) than 81.82% of its industry peers.
With a decent Return On Invested Capital value of 8.86%, AJ91 is doing good in the industry, outperforming 63.64% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for AJ91 is in line with the industry average of 9.28%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.09% | ||
| ROE | 13.18% | ||
| ROIC | 8.86% |
ROA(3y)7.87%
ROA(5y)12.82%
ROE(3y)11.84%
ROE(5y)19.17%
ROIC(3y)9.31%
ROIC(5y)15.17%
1.3 Margins
AJ91 has a better Profit Margin (9.82%) than 72.73% of its industry peers.
In the last couple of years the Profit Margin of AJ91 has remained more or less at the same level.
The Operating Margin of AJ91 (12.33%) is better than 72.73% of its industry peers.
In the last couple of years the Operating Margin of AJ91 has declined.
Looking at the Gross Margin, with a value of 79.18%, AJ91 is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
In the last couple of years the Gross Margin of AJ91 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.33% | ||
| PM (TTM) | 9.82% | ||
| GM | 79.18% |
OM growth 3Y-13.6%
OM growth 5Y-2.73%
PM growth 3Y-9.54%
PM growth 5Y0.26%
GM growth 3Y11.03%
GM growth 5Y-0.26%
2. Health
2.1 Basic Checks
AJ91 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for AJ91 remains at a similar level compared to 1 year ago.
AJ91 has more shares outstanding than it did 5 years ago.
AJ91 has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.17 indicates that AJ91 is not in any danger for bankruptcy at the moment.
AJ91 has a better Altman-Z score (4.17) than 81.82% of its industry peers.
There is no outstanding debt for AJ91. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.17 |
ROIC/WACC1.28
WACC6.91%
2.3 Liquidity
A Current Ratio of 2.74 indicates that AJ91 has no problem at all paying its short term obligations.
AJ91 has a better Current ratio (2.74) than 81.82% of its industry peers.
AJ91 has a Quick Ratio of 2.50. This indicates that AJ91 is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.50, AJ91 belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.74 | ||
| Quick Ratio | 2.5 |
3. Growth
3.1 Past
AJ91 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 133.18%, which is quite impressive.
AJ91 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.57% yearly.
AJ91 shows a small growth in Revenue. In the last year, the Revenue has grown by 0.69%.
Measured over the past years, AJ91 shows a quite strong growth in Revenue. The Revenue has been growing by 10.68% on average per year.
EPS 1Y (TTM)133.18%
EPS 3Y-22.65%
EPS 5Y10.57%
EPS Q2Q%501.79%
Revenue 1Y (TTM)0.69%
Revenue growth 3Y-14.46%
Revenue growth 5Y10.68%
Sales Q2Q%7.91%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 10.58, which indicates a very decent valuation of AJ91.
81.82% of the companies in the same industry are more expensive than AJ91, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of AJ91 to the average of the S&P500 Index (26.39), we can say AJ91 is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.58 | ||
| Fwd PE | N/A |
4.2 Price Multiples
90.91% of the companies in the same industry are more expensive than AJ91, based on the Enterprise Value to EBITDA ratio.
AJ91's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AJ91 is cheaper than 90.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.57 | ||
| EV/EBITDA | 3.16 |
4.3 Compensation for Growth
The decent profitability rating of AJ91 may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 6.76%, AJ91 is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.30, AJ91 pays a better dividend. On top of this AJ91 pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.87, AJ91 pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.76% |
5.2 History
The dividend of AJ91 has a limited annual growth rate of 4.52%.
Dividend Growth(5Y)4.52%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
48.02% of the earnings are spent on dividend by AJ91. This is a bit on the high side, but may be sustainable.
The dividend of AJ91 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP48.02%
EPS Next 2YN/A
EPS Next 3YN/A
FRA:AJ91 (12/19/2025, 7:00:00 PM)
11
-0.1 (-0.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners8.71%
Inst Owner ChangeN/A
Ins Owners71.92%
Ins Owner ChangeN/A
Market Cap55.77M
Revenue(TTM)53.79M
Net Income(TTM)5.28M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.76% |
Yearly Dividend0.5
Dividend Growth(5Y)4.52%
DP48.02%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.58 | ||
| Fwd PE | N/A | ||
| P/S | 1.04 | ||
| P/FCF | 8.57 | ||
| P/OCF | 7.3 | ||
| P/B | 1.39 | ||
| P/tB | 1.4 | ||
| EV/EBITDA | 3.16 |
EPS(TTM)1.04
EY9.45%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.28
FCFY11.67%
OCF(TTM)1.51
OCFY13.7%
SpS10.61
BVpS7.91
TBVpS7.87
PEG (NY)N/A
PEG (5Y)1
Graham Number13.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.09% | ||
| ROE | 13.18% | ||
| ROCE | 14.96% | ||
| ROIC | 8.86% | ||
| ROICexc | 17.58% | ||
| ROICexgc | 17.72% | ||
| OM | 12.33% | ||
| PM (TTM) | 9.82% | ||
| GM | 79.18% | ||
| FCFM | 12.1% |
ROA(3y)7.87%
ROA(5y)12.82%
ROE(3y)11.84%
ROE(5y)19.17%
ROIC(3y)9.31%
ROIC(5y)15.17%
ROICexc(3y)16.17%
ROICexc(5y)32.75%
ROICexgc(3y)16.36%
ROICexgc(5y)34.31%
ROCE(3y)15.72%
ROCE(5y)25.61%
ROICexgc growth 3Y-26.82%
ROICexgc growth 5Y-2.82%
ROICexc growth 3Y-26.26%
ROICexc growth 5Y-1.57%
OM growth 3Y-13.6%
OM growth 5Y-2.73%
PM growth 3Y-9.54%
PM growth 5Y0.26%
GM growth 3Y11.03%
GM growth 5Y-0.26%
F-Score6
Asset Turnover0.93
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 45.88% | ||
| Cap/Sales | 2.11% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.94% | ||
| Profit Quality | 123.15% | ||
| Current Ratio | 2.74 | ||
| Quick Ratio | 2.5 | ||
| Altman-Z | 4.17 |
F-Score6
WACC6.91%
ROIC/WACC1.28
Cap/Depr(3y)102.11%
Cap/Depr(5y)131.26%
Cap/Sales(3y)5.41%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)133.18%
EPS 3Y-22.65%
EPS 5Y10.57%
EPS Q2Q%501.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.69%
Revenue growth 3Y-14.46%
Revenue growth 5Y10.68%
Sales Q2Q%7.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y86.96%
EBIT growth 3Y-26.09%
EBIT growth 5Y7.66%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y15.74%
FCF growth 3Y-1.99%
FCF growth 5Y54.46%
OCF growth 1Y1.69%
OCF growth 3Y-11.25%
OCF growth 5Y33.53%
DOCCHECK AG / AJ91.DE FAQ
Can you provide the ChartMill fundamental rating for DOCCHECK AG?
ChartMill assigns a fundamental rating of 7 / 10 to AJ91.DE.
Can you provide the valuation status for DOCCHECK AG?
ChartMill assigns a valuation rating of 5 / 10 to DOCCHECK AG (AJ91.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for DOCCHECK AG?
DOCCHECK AG (AJ91.DE) has a profitability rating of 7 / 10.
What is the valuation of DOCCHECK AG based on its PE and PB ratios?
The Price/Earnings (PE) ratio for DOCCHECK AG (AJ91.DE) is 10.58 and the Price/Book (PB) ratio is 1.39.
Can you provide the dividend sustainability for AJ91 stock?
The dividend rating of DOCCHECK AG (AJ91.DE) is 8 / 10 and the dividend payout ratio is 48.02%.